Measured outcomes
The primary outcome assessed was: is surgeon or hospital volume
associated with the rate of mitral valve repair in myxomatous
degeneration. A secondary outcome evaluated was: is 30-day mortality
associated with mitral valve repair in myxomatous degeneration, taking
into account surgeon and or hospital volume.